ScholarLens Back to search
2011•Zhongguo xin yao zazhiRequires access

Treatment of irritable bowel syndrome with trimebute maleate combined with medilac-S

Chen Fang-fang

Open publisher page 0 citations

Abstract

Objective: To evaluate the therapeutic effect of trimebute maleate combined with medilac-S in the treatment of irritable bowel syndrome(IBS).Methods: Sixty patients with IBS were randomly divided into two groups(n=30 in each group).They were treated with 200 mg of trimebute maleate and 500 mg of medilac-S,po,tid;or with medilac-S,po,tid,alone(control group) for four weeks.The symptoms of patients,times and physical findings of stool were observed.Results: The overall efficacy rate was 90% in combination group,which was obviously higher than that in control group(73.33%,P0.05).The effect on abdominal pain and diarrhea were significantly better in combination group than in control group(P0.05).Conclusion: Trimebute maleate in combination with medilac-S is effective in the treatment of IBS.

About this research paper

What this paper is about

Objective: To evaluate the therapeutic effect of trimebute maleate combined with medilac-S in the treatment of irritable bowel syndrome(IBS).Methods: Sixty patients with IBS were randomly divided into two groups(n=30 in each group).They were treated with 200 mg of trimebute maleate and 500 mg of medilac-S,po,tid;or with medilac-S,po,tid,alone(control group) for four weeks.The symptoms of patients,times and physical findings of stool were observed.Results: The overall efficacy rate was 90% in combination group,which was obviously higher than that in control group(73.33%,P0.05).The effect on abdominal pain and diarrhea were significantly better in combination group than in control group(P0.05).Conclusion: Trimebute maleate in combination with medilac-S is effective in the treatment of IBS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the therapeutic effect of trimebute maleate combined with medilac-S in the treatment of irritable bowel syndrome(IBS).Methods: Sixty patients with IBS were randomly divided into two groups(n=30 in each group).They were treated with 200 mg of trimebute maleate and 500 mg of medilac-S,po,tid;or with medilac-S,po,tid,alone(control group) for four weeks.The symptoms of patients,times and physical findings of stool were observed.Results: The overall efficacy rate was 90% in combination group,which was obviously higher than that in control group(73.33%,P0.05).The effect on abdominal pain and diarrhea were significantly better in combination group than in control group(P0.05).Conclusion: Trimebute maleate in combination with medilac-S is effective in the treatment of IBS.

Key concepts: Irritable bowel syndrome, Diarrhea, Medicine, Gastroenterology, Internal medicine, Abdominal pain, Therapeutic effect

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Treatment of irritable bowel syndrome with trimebute maleate combined with medilac-S — Research Paper | ScholarLens